The cancer diagnostics market size is poised to grow by $ 258.54 billion by 2030 from $ 135.16 Billion in 2022, exhibiting a CAGR of 8.4% during the forecast period 2022 to 2030.
Key Takeaway:
- By product, the consumables segment has held highest market share of 61% in 2022.
- By technology, the IVD testing segment has generated market share of 62.3% in 2022.
- By screening type, the laboratory tests segment held market share of 25.5% in 2022.
- By end-user, the hospitals and clinics segment has accounted for a market share of 53% in 2022.
- By application, the others segment has dominated the market with market share of 21.7% in 2022.
- North America has held market share of around 41.8% in 2022.
- Asia Pacific is expected to reach at a strongest CAGR over the forecast period.
The main objective of this report is to define, describe, and forecast the global market by types, application, manufacturers, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in market.
Get a Sample: https://www.precedenceresearch.com/sample/1194
COVID-19 Impact
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Major companies operating in this area
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Becton, Dickinson and Company
- GE Healthcare
- QIAGEN N.V.
- Abbott Laboratories, Inc.
- Roche Diagnostics
- Siemens Healthcare
- Philips Healthcare
- R. Bard, Inc.
- bioMérieux SA
- NeoGenomics Laboratories, Inc.
- Volpara Solutions Limited
- Hologic Inc.
- Canon Medical Systems Corporation
- PenRad Technologies Inc.
- BioNTech Diagnostics GmbH
- BioGenex
Market Segmentation
By Product
- Consumables
- Antibodies
- Kits & Reagents
- Probes
- Other Consumables
- Instruments
- Pathology-based Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- PCR Instruments
- NGS Instruments
- Microarrays
- Other Pathology-based Instruments
- Imaging Instruments
- CT Systems
- Ultrasound Systems
- MRI Systems
- Mammography Systems
- Nuclear Imaging Systems
- Biopsy Instruments
By Technology
- IVD Testing
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Next-generation Sequencing (NGS)
- Microarrays
- Flow Cytometry
- Immunoassays
- Other IVD Testing Technologies
- Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Mammography
- Ultrasound
- Biopsy Technique
By Application
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
By End Use
- Hospitals and Clinics
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Research Institutes
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Major highlights of Report:
- Figures related to sales volume, market remuneration, and segmental shares
- Featuring market dynamics
- Growth prospects and expansion graph
- PROCON study of direct & indirect sales channels
- Profiles of prominent traders, dealer, and distributors in the industry
Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa
- Industry forecasts based on region and at country level
- Data about sales volume recorded, industry share held, and profit margins amassed
- Overall remuneration and estimated growth rate for each regional market
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cancer Diagnostics Market
5.1. COVID-19 Landscape: Cancer Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cancer Diagnostics Market, By Product
8.1. Cancer Diagnostics Market, by Product Type, 2022-2030
8.1.1. Consumables (Antibodies, Kits & Reagents, Probes, Other Consumables)
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Instruments (Pathology-based Instruments, Slide Staining Systems, Tissue Processing Systems, Cell Processors, Others)
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Imaging Instruments (CT Systems, Ultrasound Systems, MRI Systems, Mammography Systems, Nuclear Imaging Systems)
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Biopsy Instruments
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Cancer Diagnostics Market, By Technology
9.1. Cancer Diagnostics Market, by Technology, 2022-2030
9.1.1. IVD Testing (PCR, ISH, IHC, NGS, Microarrays, Flow Cytometry, Immunoassays)
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Imaging (MRI, CT, PET, Mammography, Ultrasound)
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Biopsy Technique
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Cancer Diagnostics Market, By Application
10.1. Cancer Diagnostics Market, by Application, 2022-2030
10.1.1. Breast Cancer
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Colorectal Cancer
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Cervical Cancer
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Lung Cancer
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Prostate Cancer
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Skin Cancer
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. Blood Cancer
10.1.7.1. Market Revenue and Forecast (2019-2030)
10.1.8. Kidney Cancer
10.1.8.1. Market Revenue and Forecast (2019-2030)
10.1.9. Liver Cancer
10.1.9.1. Market Revenue and Forecast (2019-2030)
10.1.10. Pancreatic Cancer
10.1.10.1. Market Revenue and Forecast (2019-2030)
10.1.11. Ovarian Cancer
10.1.11.1. Market Revenue and Forecast (2019-2030)
10.1.12. Others
10.1.12.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Cancer Diagnostics Market, By End Use
11.1. Cancer Diagnostics Market, by End Use, 2022-2030
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Diagnostic Imaging Centers
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Research Institutes
11.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Technology (2019-2030)
12.1.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.4. Market Revenue and Forecast, by End Use (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End Use (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End Use (2019-2030)
Chapter 13. Company Profiles
13.1. Agilent Technologies, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Becton, Dickinson and Company
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GE Healthcare
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. QIAGEN N.V.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Roche Diagnostics
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Siemens Healthcare
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Philips Healthcare
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. R. Bard, Inc.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments